Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 15,120 | 14,629 | 14,896 | 13,030 | 19,946 |
| Cost of Goods | 4,679 | 4,471 | 5,727 | 6,002 | 2,248 |
| Gross Profit | 10,441 | 10,158 | 9,169 | 7,028 | 17,698 |
| Operating Expenses | 35,050 | 32,724 | 37,684 | 43,596 | 37,558 |
| Operating Income | -23,930 | -22,095 | -27,788 | -36,566 | -19,612 |
| Interest Expense | 2,594 | 6,209 | 2,122 | 2,602 | 2,060 |
| Other Income | 453 | 1,679 | 1,086 | 145 | -6,932 |
| Pre-tax Income | -26,071 | -26,625 | -28,824 | -39,023 | -28,604 |
| Income Tax | 243 | 69 | N/A | N/A | 380 |
| Net Income Continuous | -26,314 | -26,694 | -28,824 | -39,023 | -28,984 |
| Minority Interests | -19,549 | -13,827 | -17,876 | -23,606 | -19,705 |
| Net Income | $-6,765 | $-12,867 | $-10,948 | $-15,417 | $-9,279 |
| EPS Basic Total Ops | -0.16 | -0.76 | -0.73 | -1.04 | -0.41 |
| EPS Basic Continuous Ops | -0.61 | -1.36 | -1.57 | -2.28 | -1.42 |
| EPS Diluted Total Ops | -0.16 | -0.76 | -0.73 | -1.04 | -0.41 |
| EPS Diluted Continuous Ops | -0.61 | -1.36 | -1.57 | -2.28 | -1.42 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.76 | -0.73 | N/A | N/A |
| EBITDA(a) | $-22,025 | $-20,276 | $-24,476 | $-34,238 | $-17,395 |